4D Molecular Therapeutics, Inc. Profile Avatar - Palmy Investing

4D Molecular Therapeutics, Inc.

4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, …

Biotechnology
US, EmeryVille [HQ]
Competitors · Subsidiaries · Locations

Business Intelligence

U.S. · Business Intelligence
Worldwide · Business Intelligence
End of FDMT's Analysis
CIK: 1650648 CUSIP: 35104E100 ISIN: US35104E1001 LEI: - UEI: -
Secondary Listings
FDMT has no secondary listings inside our databases.